Dang CT - Search Results

1

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.

Iyengar NM, Smyth LM, Lake D, Gucalp A, Singh JC, Traina TA, DeFusco P, Fornier MN, Goldfarb S, Jhaveri K, Modi S, Troso-Sandoval T, Patil S, Ulaner GA, Jochelson M, Norton L, Hudis CA, Dang CT. Iyengar NM, et al. Among authors: dang ct. JAMA Netw Open. 2019 Nov 1;2(11):e1916211. doi: 10.1001/jamanetworkopen.2019.16211. JAMA Netw Open. 2019. PMID: 31774522 Free PMC article. Clinical Trial.

2

Potential role of selective COX-2 inhibitors in cancer management.

Dang CT, Shapiro CL, Hudis CA. Dang CT, et al. Oncology (Williston Park). 2002 May;16(5 Suppl 4):30-6. Oncology (Williston Park). 2002. PMID: 12102578 Free article. Review.

3

Risk models for neutropenia in patients with breast cancer.

Dang CT, Fornier MN, Hudis CA. Dang CT, et al. Oncology (Williston Park). 2003 Nov;17(11 Suppl 11):14-20. Oncology (Williston Park). 2003. PMID: 14682114 Free article. Review.

4

Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.

Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, Seidman AD, D'Andrea GM, Theodoulou M, Panageas KS, Norton L, Hudis CA. Dang CT, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4062-7. doi: 10.1158/1078-0432.CCR-03-0463. Clin Cancer Res. 2004. PMID: 15217939 Clinical Trial.

5

Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.

Dang CT, D'Andrea GM, Moynahan ME, Dickler MN, Seidman AD, Fornier M, Robson ME, Theodoulou M, Lake D, Currie VE, Hurria A, Panageas KS, Norton L, Hudis CA. Dang CT, et al. Clin Cancer Res. 2004 Sep 1;10(17):5754-61. doi: 10.1158/1078-0432.CCR-04-0634. Clin Cancer Res. 2004. PMID: 15355903 Clinical Trial.

6

Adjuvant therapy for breast cancer: practical lessons from the early breast cancer trialists' collaborative group.

Hudis CA, Dang CT. Hudis CA, et al. Among authors: dang ct. Breast Dis. 2004;21:3-13. doi: 10.3233/bd-2004-21102. Breast Dis. 2004. PMID: 15687717 Review. No abstract available.

7

Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.

Dang CT. Dang CT. Expert Rev Anticancer Ther. 2006 Mar;6(3):427-36. doi: 10.1586/14737140.6.3.427. Expert Rev Anticancer Ther. 2006. PMID: 16503859 Review.

8

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.

Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C. Hurria A, et al. Breast Cancer Res Treat. 2006 Aug;98(3):343-8. doi: 10.1007/s10549-006-9171-6. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541322

9

Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.

Dang C, Hudis C. Dang C, et al. Clin Breast Cancer. 2006 Apr;7(1):51-8. doi: 10.3816/CBC.2006.n.013. Clin Breast Cancer. 2006. PMID: 16764744 Review.

10

Can granulocyte-colony stimulating factor worsen anemia?

Dang C, Hudis C. Dang C, et al. J Clin Oncol. 2006 Jul 1;24(19):2985-6. doi: 10.1200/JCO.2006.06.1416. Epub 2006 Jun 12. J Clin Oncol. 2006. PMID: 16769981 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters